In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Laboratoires Nutrition et Cardiométabolisme

http://l-n-c.fr

Latest From Laboratoires Nutrition et Cardiométabolisme

Mining The Microbiome: Are Gut Microbes The Next Big Source Of Drugs?

There is growing interest in the gut microbiome as a source of new therapies across a wide range of diseases. Although it is still an emerging field, pharmaceutical firms and other investors are engaging, with more expected to follow.

BioPharmaceutical

Laboratoires Nutrition et Cardiométabolisme

Laboratoires Nutrition et Cardiométabolisme aims to combat obesity and metabolic disease with a range of prescription-only medical nutrition products.

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Laboratoires Nutrition et Cardiométabolisme
  • Senior Management
  • Jean-Luc Treillou, CEO
    Fabrice Guez, Fin. Dir.
  • Contact Info
  • Laboratoires Nutrition et Cardiométabolisme
    Phone: 5 57 83 19 18
    38, cours Clémenceau
    Bordeaux, 33000
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register